Suppr超能文献

别构调节大麻素 G 蛋白偶联受体:结合位点阐明及其与 G 蛋白信号转导的关系。

Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.

机构信息

From the Center for Drug Discovery, University of North Carolina at Greensboro, Greensboro, North Carolina 27402.

出版信息

J Biol Chem. 2014 Feb 28;289(9):5828-45. doi: 10.1074/jbc.M113.478495. Epub 2013 Dec 23.

Abstract

The cannabinoid 1 (CB1) allosteric modulator, 5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide) (ORG27569), has the paradoxical effect of increasing the equilibrium binding of (3)H-3-[2-hydroxyl-4-(1,1-dimethylheptyl)phenyl]-4-[3-hydroxylpropyl]cyclohexan-1-ol (CP55,940, an orthosteric agonist) while at the same time decreasing its efficacy (in G protein-mediated signaling). ORG27569 also decreases basal signaling, acting as an inverse agonist for the G protein-mediated signaling pathway. In ligand displacement assays, ORG27569 can displace the CB1 antagonist/inverse agonist, N-(piperidiny-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide(SR141716A). The goal of this work was to identify the binding site of ORG27569 at CB1. To this end, we used computation, synthesis, mutation, and functional studies to identify the ORG27569-binding site in the CB1 TMH3-6-7 region. This site is consistent with the results of K3.28(192)A, F3.36(200)A, W5.43(279)A, W6.48(356)A, and F3.25(189)A mutation studies, which revealed the ORG27569-binding site overlaps with our previously determined binding site of SR141716A but extends extracellularly. Additionally, we identified a key electrostatic interaction between the ORG27569 piperidine ring nitrogen and K3.28(192) that is important for ORG27569 to act as an inverse agonist. At this allosteric site, ORG27569 promotes an intermediate conformation of the CB1 receptor, explaining ORG27569's ability to increase equilibrium binding of CP55,940. This site also explains ORG27569's ability to antagonize the efficacy of CP55,940 in three complementary ways. 1) ORG27569 sterically blocks movements of the second extracellular loop that have been linked to receptor activation. 2) ORG27569 sterically blocks a key electrostatic interaction between the third extracellular loop residue Lys-373 and D2.63(176). 3) ORG27569 packs against TMH6, sterically hindering movements of this helix that have been shown to be important for receptor activation.

摘要

大麻素 1 型(CB1)别构调节剂,5-氯-3-乙基-1H-吲哚-2-羧酸[2-(4-哌啶-1-基-苯基)-乙基]-酰胺](ORG27569)具有增加平衡结合的矛盾作用[(3)H](-)-3-[2-羟基-4-(1,1-二甲基庚基)苯基]-4-[3-羟基丙基]环己烷-1-醇(CP55,940,一个正位激动剂),同时降低其功效(在 G 蛋白介导的信号转导中)。ORG27569 还降低基础信号,作为 G 蛋白介导的信号通路的反向激动剂。在配体置换测定中,ORG27569 可以置换 CB1 拮抗剂/反向激动剂,N-(哌啶基-1-基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-羧酰胺(SR141716A)。这项工作的目的是确定 ORG27569 在 CB1 中的结合位点。为此,我们使用计算、合成、突变和功能研究来确定 CB1 TMH3-6-7 区域中 ORG27569 的结合位点。该位点与 K3.28(192)A、F3.36(200)A、W5.43(279)A、W6.48(356)A 和 F3.25(189)突变研究的结果一致,这些研究表明 ORG27569 的结合位点与我们先前确定的 SR141716A 的结合位点重叠,但向细胞外延伸。此外,我们还确定了 ORG27569 哌啶环氮与 K3.28(192)之间的关键静电相互作用,这对于 ORG27569 作为反向激动剂很重要。在这个别构位点,ORG27569 促进 CB1 受体的中间构象,解释了 ORG27569 增加 CP55,940 平衡结合的能力。该位点还解释了 ORG27569 以三种互补方式拮抗 CP55,940 功效的能力。1)ORG27569 空间上阻止与受体激活相关的第二细胞外环的运动。2)ORG27569 空间上阻止第三细胞外环残基赖氨酸 373 和 D2.63(176)之间的关键静电相互作用。3)ORG27569 与 TMH6 结合,阻碍该螺旋的运动,该螺旋的运动已被证明对受体激活很重要。

相似文献

1
Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.
J Biol Chem. 2014 Feb 28;289(9):5828-45. doi: 10.1074/jbc.M113.478495. Epub 2013 Dec 23.
3
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
Mol Pharmacol. 2015 Aug;88(2):368-79. doi: 10.1124/mol.115.099192. Epub 2015 Jun 4.
6
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
Behav Pharmacol. 2014 Apr;25(2):182-5. doi: 10.1097/FBP.0000000000000027.
7
Parameterization of Org27569: an allosteric modulator of the cannabinoid CB1 G protein-coupled receptor.
J Comput Chem. 2011 Jul 30;32(10):2119-26. doi: 10.1002/jcc.21794. Epub 2011 Apr 27.

引用本文的文献

2
Should oncologists trust cannabinoids?
Front Pharmacol. 2023 Jul 13;14:1211506. doi: 10.3389/fphar.2023.1211506. eCollection 2023.
3
Endocannabinoid signaling in the central nervous system.
Glia. 2023 Jan;71(1):5-35. doi: 10.1002/glia.24280. Epub 2022 Oct 29.
4
Negative allosteric modulation of CB cannabinoid receptor signaling suppresses opioid-mediated reward.
Pharmacol Res. 2022 Nov;185:106474. doi: 10.1016/j.phrs.2022.106474. Epub 2022 Sep 28.
5
Covalent cannabinoid receptor ligands - structural insight and selectivity challenges.
RSC Med Chem. 2022 Apr 4;13(5):497-510. doi: 10.1039/d2md00006g. eCollection 2022 May 25.
6
G protein-coupled receptors: structure- and function-based drug discovery.
Signal Transduct Target Ther. 2021 Jan 8;6(1):7. doi: 10.1038/s41392-020-00435-w.
7
Hemopressin as a breakthrough for the cannabinoid field.
Neuropharmacology. 2021 Feb 1;183:108406. doi: 10.1016/j.neuropharm.2020.108406. Epub 2020 Nov 16.
8
Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options.
Neuronal Signal. 2018 Nov 2;2(4):NS20170144. doi: 10.1042/NS20170144. eCollection 2018 Dec.
9
A Guide to Targeting the Endocannabinoid System in Drug Design.
Int J Mol Sci. 2020 Apr 16;21(8):2778. doi: 10.3390/ijms21082778.
10
Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities.
Int J Mol Sci. 2019 Nov 22;20(23):5874. doi: 10.3390/ijms20235874.

本文引用的文献

3
CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity.
Mol Pharmacol. 2013 Feb;83(2):322-38. doi: 10.1124/mol.112.080879. Epub 2012 Nov 15.
4
5
Emerging opportunities for allosteric modulation of G-protein coupled receptors.
Biochem Pharmacol. 2013 Jan 15;85(2):153-62. doi: 10.1016/j.bcp.2012.09.001. Epub 2012 Sep 11.
6
A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569.
J Biol Chem. 2012 Sep 28;287(40):33873-82. doi: 10.1074/jbc.M112.352328. Epub 2012 Jul 30.
7
Indole-2-carboxamides as allosteric modulators of the cannabinoid CB₁ receptor.
J Med Chem. 2012 Jun 14;55(11):5627-31. doi: 10.1021/jm201485c. Epub 2012 May 17.
8
The role of the second and third extracellular loops of the adenosine A1 receptor in activation and allosteric modulation.
Biochem Pharmacol. 2012 Jul 1;84(1):76-87. doi: 10.1016/j.bcp.2012.03.008. Epub 2012 Mar 23.
9
Crystal structure of a lipid G protein-coupled receptor.
Science. 2012 Feb 17;335(6070):851-5. doi: 10.1126/science.1215904.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验